Cargando…

Plasma membrane expression of ZNF185 is a prognostic factor in pancreatic ductal carcinoma

Pancreatic ductal carcinoma (PDC) is one of the major causes of cancer-associated mortality globally due to its high potential for distant metastasis. To understand hematogenous metastasis, the molecular expression profiles of weak metastatic PDC cell subline BxPC-3 and highly liver-metastatic cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Furukawa, Daisuke, Chijiwa, Tsuyoshi, Matsuyama, Masahiro, Mukai, Masaya, Matsuo, Ei-Ichi, Nishimura, Osamu, Kawai, Kenji, Suemizu, Hiroshi, Nakagohri, Toshio, Ozawa, Soji, Shimada, Kazuaki, Hiraoka, Nobuyoshi, Nakamura, Masato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587964/
https://www.ncbi.nlm.nih.gov/pubmed/28927124
http://dx.doi.org/10.3892/ol.2017.6633
_version_ 1783262093635485696
author Furukawa, Daisuke
Chijiwa, Tsuyoshi
Matsuyama, Masahiro
Mukai, Masaya
Matsuo, Ei-Ichi
Nishimura, Osamu
Kawai, Kenji
Suemizu, Hiroshi
Nakagohri, Toshio
Ozawa, Soji
Shimada, Kazuaki
Hiraoka, Nobuyoshi
Nakamura, Masato
author_facet Furukawa, Daisuke
Chijiwa, Tsuyoshi
Matsuyama, Masahiro
Mukai, Masaya
Matsuo, Ei-Ichi
Nishimura, Osamu
Kawai, Kenji
Suemizu, Hiroshi
Nakagohri, Toshio
Ozawa, Soji
Shimada, Kazuaki
Hiraoka, Nobuyoshi
Nakamura, Masato
author_sort Furukawa, Daisuke
collection PubMed
description Pancreatic ductal carcinoma (PDC) is one of the major causes of cancer-associated mortality globally due to its high potential for distant metastasis. To understand hematogenous metastasis, the molecular expression profiles of weak metastatic PDC cell subline BxPC-3 and highly liver-metastatic cell subline LM-BxPC-3 were compared, and zinc finger protein 185 (ZNF185) was identified as a molecule that is upregulated in LM-BxPC-3 cells. The aim of the present study was to evaluate the clinicopathological significance of ZNF185 in PDC. Using immunohistochemistry, ZNF185 expression was investigated in 182 patients with PDC, in association with numerous clinicopathological variables. The expression profile of ZNF185 was also characterized using xenograft models. In contrast to parent BxPC-3 cells in subcutaneous transplanted tumor foci, which only expressed ZNF185 on their plasma membrane (m)ZNF185, LM-BxPC-3 cells in liver-metastatic foci that were formed subsequent to transplantation all expressed cytoplasmic (c)ZNF185. Additionally, 51% of the cells at the periphery of the tumor foci expressed mZNF185. Expression of cZNF185, and of mZNF185 and cZNF185 combined was identified in 93 and 39% of clinical patients with PDC, respectively. Patients with mZNF185-negative and -positive PDC exhibited a median survival time of 30.2 months and 21.3 months, respectively. Multivariate analysis indicated that the expression of mZNF185 is closely associated with a shorter overall survival time. Increased marked venous invasion was more prevalent in patients who were mZNF185-positive, as compared with patients who were mZNF185-negative. These data suggest that the expression of mZNF185 is an independent and unfavorable prognosticator in patients with PDC. The results suggested that the amount and subcellular location of ZNF185 are correlated with the position of the cancer cells expressing it within the nests. Additionally, the subcellular location of ZNF185 may be important to its biological function.
format Online
Article
Text
id pubmed-5587964
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-55879642017-09-18 Plasma membrane expression of ZNF185 is a prognostic factor in pancreatic ductal carcinoma Furukawa, Daisuke Chijiwa, Tsuyoshi Matsuyama, Masahiro Mukai, Masaya Matsuo, Ei-Ichi Nishimura, Osamu Kawai, Kenji Suemizu, Hiroshi Nakagohri, Toshio Ozawa, Soji Shimada, Kazuaki Hiraoka, Nobuyoshi Nakamura, Masato Oncol Lett Articles Pancreatic ductal carcinoma (PDC) is one of the major causes of cancer-associated mortality globally due to its high potential for distant metastasis. To understand hematogenous metastasis, the molecular expression profiles of weak metastatic PDC cell subline BxPC-3 and highly liver-metastatic cell subline LM-BxPC-3 were compared, and zinc finger protein 185 (ZNF185) was identified as a molecule that is upregulated in LM-BxPC-3 cells. The aim of the present study was to evaluate the clinicopathological significance of ZNF185 in PDC. Using immunohistochemistry, ZNF185 expression was investigated in 182 patients with PDC, in association with numerous clinicopathological variables. The expression profile of ZNF185 was also characterized using xenograft models. In contrast to parent BxPC-3 cells in subcutaneous transplanted tumor foci, which only expressed ZNF185 on their plasma membrane (m)ZNF185, LM-BxPC-3 cells in liver-metastatic foci that were formed subsequent to transplantation all expressed cytoplasmic (c)ZNF185. Additionally, 51% of the cells at the periphery of the tumor foci expressed mZNF185. Expression of cZNF185, and of mZNF185 and cZNF185 combined was identified in 93 and 39% of clinical patients with PDC, respectively. Patients with mZNF185-negative and -positive PDC exhibited a median survival time of 30.2 months and 21.3 months, respectively. Multivariate analysis indicated that the expression of mZNF185 is closely associated with a shorter overall survival time. Increased marked venous invasion was more prevalent in patients who were mZNF185-positive, as compared with patients who were mZNF185-negative. These data suggest that the expression of mZNF185 is an independent and unfavorable prognosticator in patients with PDC. The results suggested that the amount and subcellular location of ZNF185 are correlated with the position of the cancer cells expressing it within the nests. Additionally, the subcellular location of ZNF185 may be important to its biological function. D.A. Spandidos 2017-09 2017-07-20 /pmc/articles/PMC5587964/ /pubmed/28927124 http://dx.doi.org/10.3892/ol.2017.6633 Text en Copyright: © Furukawa et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Furukawa, Daisuke
Chijiwa, Tsuyoshi
Matsuyama, Masahiro
Mukai, Masaya
Matsuo, Ei-Ichi
Nishimura, Osamu
Kawai, Kenji
Suemizu, Hiroshi
Nakagohri, Toshio
Ozawa, Soji
Shimada, Kazuaki
Hiraoka, Nobuyoshi
Nakamura, Masato
Plasma membrane expression of ZNF185 is a prognostic factor in pancreatic ductal carcinoma
title Plasma membrane expression of ZNF185 is a prognostic factor in pancreatic ductal carcinoma
title_full Plasma membrane expression of ZNF185 is a prognostic factor in pancreatic ductal carcinoma
title_fullStr Plasma membrane expression of ZNF185 is a prognostic factor in pancreatic ductal carcinoma
title_full_unstemmed Plasma membrane expression of ZNF185 is a prognostic factor in pancreatic ductal carcinoma
title_short Plasma membrane expression of ZNF185 is a prognostic factor in pancreatic ductal carcinoma
title_sort plasma membrane expression of znf185 is a prognostic factor in pancreatic ductal carcinoma
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587964/
https://www.ncbi.nlm.nih.gov/pubmed/28927124
http://dx.doi.org/10.3892/ol.2017.6633
work_keys_str_mv AT furukawadaisuke plasmamembraneexpressionofznf185isaprognosticfactorinpancreaticductalcarcinoma
AT chijiwatsuyoshi plasmamembraneexpressionofznf185isaprognosticfactorinpancreaticductalcarcinoma
AT matsuyamamasahiro plasmamembraneexpressionofznf185isaprognosticfactorinpancreaticductalcarcinoma
AT mukaimasaya plasmamembraneexpressionofznf185isaprognosticfactorinpancreaticductalcarcinoma
AT matsuoeiichi plasmamembraneexpressionofznf185isaprognosticfactorinpancreaticductalcarcinoma
AT nishimuraosamu plasmamembraneexpressionofznf185isaprognosticfactorinpancreaticductalcarcinoma
AT kawaikenji plasmamembraneexpressionofznf185isaprognosticfactorinpancreaticductalcarcinoma
AT suemizuhiroshi plasmamembraneexpressionofznf185isaprognosticfactorinpancreaticductalcarcinoma
AT nakagohritoshio plasmamembraneexpressionofznf185isaprognosticfactorinpancreaticductalcarcinoma
AT ozawasoji plasmamembraneexpressionofznf185isaprognosticfactorinpancreaticductalcarcinoma
AT shimadakazuaki plasmamembraneexpressionofznf185isaprognosticfactorinpancreaticductalcarcinoma
AT hiraokanobuyoshi plasmamembraneexpressionofznf185isaprognosticfactorinpancreaticductalcarcinoma
AT nakamuramasato plasmamembraneexpressionofznf185isaprognosticfactorinpancreaticductalcarcinoma